tetano
Editor, Senior Moderator
Heliyon
. 2020 Aug 20;e04658.
doi: 10.1016/j.heliyon.2020.e04658. Online ahead of print.
Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies
Rahila Sardar[SUP] 1 2 [/SUP], Deepshikha Satish[SUP] 1 [/SUP], Shweta Birla[SUP] 1 [/SUP], Dinesh Gupta[SUP] 1 [/SUP]
Affiliations
Abstract
We have performed an integrative analysis of SARS-CoV-2 genome sequences from different countries. Apart from mutational analysis, we have predicted host antiviral miRNAs targeting virus genes, PTMs in the virus proteins and antiviral peptides. A comparison of the analyses with other coronavirus genomes has been performed, wherever possible. Our analysis confirms unique features in the SARS-CoV-2 genomes absent in other evolutionarily related coronavirus family genomes, which presumably confer unique infection, transmission and virulence capabilities to the virus. For understanding the crucial factors involved in host-virus interactions, we have performed Bioinformatics aided analysis integrated with experimental data related to other corona viruses. We have identified 42 conserved miRNAs that can potentially target SARS-CoV-2 genomes. Interestingly, out of these, 3 are previously reported to exhibit antiviral activity against other respiratory viruses. Gene expression analysis of known host antiviral factors reveals significant over-expression of IFITM3 and down regulation of cathepsins during SARS-CoV-2 infection, suggesting its active role in pathogenesis and delayed immune response. We also predicted antiviral peptides which can be used in designing peptide based drugs against SARS-CoV-2. Our analysis explores the functional impact of the virus mutations on its proteins and interaction of its genes with host antiviral mechanisms.
Keywords: Bioinformatics; Coronavirus; Genetics; Infectious Disease; Virology; antiviral miRNA; antiviral peptides.
. 2020 Aug 20;e04658.
doi: 10.1016/j.heliyon.2020.e04658. Online ahead of print.
Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies
Rahila Sardar[SUP] 1 2 [/SUP], Deepshikha Satish[SUP] 1 [/SUP], Shweta Birla[SUP] 1 [/SUP], Dinesh Gupta[SUP] 1 [/SUP]
Affiliations
- PMID: 32844125
- PMCID: PMC7439967
- DOI: 10.1016/j.heliyon.2020.e04658
Abstract
We have performed an integrative analysis of SARS-CoV-2 genome sequences from different countries. Apart from mutational analysis, we have predicted host antiviral miRNAs targeting virus genes, PTMs in the virus proteins and antiviral peptides. A comparison of the analyses with other coronavirus genomes has been performed, wherever possible. Our analysis confirms unique features in the SARS-CoV-2 genomes absent in other evolutionarily related coronavirus family genomes, which presumably confer unique infection, transmission and virulence capabilities to the virus. For understanding the crucial factors involved in host-virus interactions, we have performed Bioinformatics aided analysis integrated with experimental data related to other corona viruses. We have identified 42 conserved miRNAs that can potentially target SARS-CoV-2 genomes. Interestingly, out of these, 3 are previously reported to exhibit antiviral activity against other respiratory viruses. Gene expression analysis of known host antiviral factors reveals significant over-expression of IFITM3 and down regulation of cathepsins during SARS-CoV-2 infection, suggesting its active role in pathogenesis and delayed immune response. We also predicted antiviral peptides which can be used in designing peptide based drugs against SARS-CoV-2. Our analysis explores the functional impact of the virus mutations on its proteins and interaction of its genes with host antiviral mechanisms.
Keywords: Bioinformatics; Coronavirus; Genetics; Infectious Disease; Virology; antiviral miRNA; antiviral peptides.